Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts

Frontiers in Psychiatry
Udo BonnetNorbert Scherbaum

Abstract

Background: Over the past 15 years, comparative assessments of psychoactive substance harms to both users and others have been compiled by addiction experts. None of these rankings however have included synthetic cannabinoids or non-opioid prescription analgesics (NOAs, e.g., gabapentinoids) despite evidence of increasing recreational use. We present here an updated assessment by German addiction medicine experts, considering changing Western consumption trends-including those of NOAs. Methods: In an initial survey, 101 German addiction medicine physicians evaluated both physical and psychosocial harms (in 5 dimensions) of 33 psychoactive substances including opioids and NOAs, to both users and others. In a second survey, 36 addiction medicine physicians estimated the relative weight of each health and social harm dimension to determine the overall harm rank of an individual substance. We compared our ranking with the most recent European assessment from 2014. Results: Illicit drugs such as methamphetamine, heroin, cocaine and also alcohol were judged particularly harmful, and new psychoactive drugs (cathinones, synthetic cannabinoids) were ranked among the most harmful substances. Cannabis was ranked in the midrange, on par wi...Continue Reading

References

Mar 12, 2008·Der Nervenarzt·F HölscherN Scherbaum
Dec 22, 2009·European Journal of Clinical Pharmacology·Frédérique Beau-SalinasElisabeth Autret-Leca
Jul 8, 2010·European Addiction Research·Jan van AmsterdamWim van den Brink
Nov 3, 2010·Lancet·David J NuttUNKNOWN Independent Scientific Committee on Drugs
Jun 10, 2011·The International Journal on Drug Policy·Stephen Rolles, Fiona Measham
Aug 3, 2011·Fortschritte der Neurologie-Psychiatrie·U Bonnet
Oct 1, 2011·Addiction·Catherine BourgainMichel Reynaud
Sep 17, 2013·Journal of Clinical Pharmacology·Maximilian GahrCarlos Schönfeldt-Lecuona
Apr 26, 2014·Pharmacopsychiatry·F EtcheverrigarayC Victorri-Vigneau
May 14, 2014·Pharmacoepidemiology and Drug Safety·Shahrul Mt-IsaUNKNOWN IMI-PROTECT benefit-risk participants
Apr 30, 2015·Journal of Psychopharmacology·Jan van AmsterdamWim van den Brink
Sep 19, 2015·Regulatory Toxicology and Pharmacology : RTP·Jan van AmsterdamDavid Nutt
Sep 26, 2015·Pharmacological Reviews·Esa R KorpiGavin S Dawe
Jan 23, 2016·Deutsche medizinische Wochenschrift·Udo BonnetNorbert Scherbaum
Sep 15, 2016·Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University·Monika Wójta-Kempa, Dominik M Krzyżanowski
Nov 21, 2016·The American Journal of the Medical Sciences·Byron CryerC Mel Wilcox
Feb 2, 2017·Drugs·Kirk E EvoyStephen R Saklad
Feb 20, 2017·Addictive Behaviors·Margo E GoderskyRichard Saitz
Apr 27, 2017·Pharmacopsychiatry·Norbert ScherbaumUdo Bonnet
Oct 11, 2017·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·U Bonnet, N Scherbaum
Dec 1, 2017·Expert Opinion on Pharmacotherapy·Maurice DematteisMichael Soyka
Jul 30, 2018·International Journal of Legal Medicine·Federica FotiFabio De-Giorgio
Jan 24, 2019·European Archives of Psychiatry and Clinical Neuroscience·Suman ChandraMahmoud A ElSohly
Apr 10, 2019·Deutsches Ärzteblatt International·Ludwig KrausTim Pfeiffer-Gerschel
May 14, 2019·Journal of Psychopharmacology·Yvonne BonomoDavid Castle
Oct 8, 2019·Deutsches Ärzteblatt International·Nicki-Nils SeitzLudwig Kraus
Nov 27, 2019·British Journal of Clinical Pharmacology·John Martin CorkeryGiovanni Martinotti
Feb 12, 2020·Journal of the Neurological Sciences·Tingying Chi, Jessica A Gold

❮ Previous
Next ❯

Citations

Aug 1, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rebekah BrennanMarie Claire Van Hout

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.